Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2010
12/01/2010CN101897831A Method for extracting and separating medlar total alkaloids from medlar
12/01/2010CN101897782A Chinese medicinal preparation for treating carcinoma of uterine cervix
12/01/2010CN101897740A Glabrous sarcandra herb formula particle and preparation method thereof
12/01/2010CN101897718A Growth inhibitor for tumor vessels
12/01/2010CN101897705A Compound having function of resisting tumor activity
12/01/2010CN101897668A Oxaliplatin liposome, preparation method and application thereof
12/01/2010CN101897667A Doxorubicin hydrochloride liposome injection and preparation technology thereof
12/01/2010CN101897663A Stable tegafur injection formula and preparation process thereof
12/01/2010CN101653439B Application of C60-benzoic nitrogen mustard in preparing antitumor medicament
12/01/2010CN101597572B Oxytropis ehrig sporangium FEL6-AS2 for synthesizing SW and application thereof
12/01/2010CN101548974B Compound having fluorescent characteristic and anti-cancer activity, preparation thereof and application thereof
12/01/2010CN101518525B Preparation method for semi-pinnated brake herb extract injection
12/01/2010CN101514326B Oxytropis ehrig verticillium FEL5-AS1 of synthesized swainsonine and application thereof
12/01/2010CN101417135B Preparation method of biodegradable fallout radioactive material for treating cancer
12/01/2010CN101407810B Small interfering RNA with midkine gene as target, vector and use thereof
12/01/2010CN101401792B Method for preparing nanocapsule and nanocapsule composite microsphere
12/01/2010CN101396354B Stable taxabe compound liquid combination and preparation method and use thereof
12/01/2010CN101391989B Method for preparing polyhydroxy taxone and paclitaxel
12/01/2010CN101391004B Medicine composition for treating late-stage esophageal carcinoma
12/01/2010CN101386625B Vinflunine derivates and preparation method thereof and application thereof in preparing medicament for targeted therapy solid tumors, liver cancer or lung cancer
12/01/2010CN101380473B Gold nano-bar based medicine carrier and preparation technique and use thereof
12/01/2010CN101342142B Temperature sensing in situ gel rubber formulations capable of being injected, preparation method and uses thereof
12/01/2010CN101323643B Optimized TACI-Fc fuse protein
12/01/2010CN101293904B New compound, preparation method and application thereof
12/01/2010CN101270144B Saponin for inhibiting liveness of tumor necrosis factor alpha, preparing method and medicine uses
12/01/2010CN101259099B Nano granule preparations of catharanthus roseus alkaloids anti-tumor medicaments and preparation thereof
12/01/2010CN101230082B 23-hydroxy betulinic acid derivative, preparation method, preparation and use thereof
12/01/2010CN101204405B Extractive of locust tree microellobosporia, preparation method and uses thereof
12/01/2010CN101161290B Beta-elemi alkene polyglycol amine derivant as well as its synthesis method and purpose
12/01/2010CN101139335B Use of 7-hydroxy-3-[(4-hydroxy)-3-((E)-3,7-dimethyl-octyl-2,6-diolefin)phenyl]-4H-1-benzopyran-4-ketone
12/01/2010CN101111241B Antineoplastic preparation and the use of antineoplastic preparation
12/01/2010CN101077356B Application for polysaccharide extraction of grateloupia filicina in preparing antitumor medicine
12/01/2010CN101058808B Breast cancer relevant p60 gene, coding protein and application thereof
12/01/2010CN100999520B Isoandrographolide analogue and its preparation process
11/2010
11/30/2010US7842822 (3aS, 4S, 9bS)-4-(4-Hydroxy-phenyl)-1,3a,4,9b-tetrahydro-3H-2,5-dioxa-cyclopenta[a]naphthalen-8-ol, used for the treatment of benign prostatic hyperplasia, cardiovascular diseases, neurodegenerative disorders, incontinence, nervous system disorders, gastrointestinal disorders and osteoporosis
11/30/2010US7842805 1-arylamino-phthalazines such as 5-Fluorophthalazin-1-yl)-(4-methoxyphenyl)-methyl-amine or 4-arylamino-benzo[d][1,2,3]triazines such as Benzo[d][1,2,3]triazin-4-y1-(4-methoxy-pheny1)-methyl-amine, used as anticarcinogenic agents or for the treatment of psoriasis, autoimmune diseases and fungi infections
11/30/2010US7842797 Human CDR-grafted antibody and antibody fragment thereof
11/30/2010US7842787 Kinase insert domain-containing receptor (KDR) specific immunoglobulin for monitoring tumor angiogenesis
11/30/2010US7842782 Heparanase-derived peptides for vaccination of tumor patients
11/30/2010US7842724 Pharmaceutical gallium compositions and methods
11/30/2010US7842705 Curcumin analogs with anti-tumor and anti-angiogenic properties
11/30/2010US7842701 tyrosine kinase inhibitors such as 3-amino-2-(2-chloro-5-hydroxyphenyl)-7-(3-morpholin-4-ylpropoxy)-2,5-dihydro-4H-pyrazolo[4,3-c]quinolin-4-one, used as anticarcinogenic or antiproliferative agents
11/30/2010US7842699 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases
11/30/2010US7842698 Autoimmune diseases; antiinflamamtory agents, cardiovascular disorders; neurodegenerative diseases, kidney diseases, anticancer agents; platelet aggregation
11/30/2010US7842687 Cephalotaxane derivatives and their processes of preparation and purification
11/30/2010US7842671 Blocking cancer cells; antiproliferative agents; inducting apoptosis; anticancer, antitumor agents; peptidomimetics
11/30/2010US7842314 periodically administering neuraminidase to a lukemia patient
11/30/2010US7842293 Compositions and methods using anti-CS1 antibodies to treat multiple myeloma
11/30/2010CA2497444C Pyrazolopyrimidines as cyclin dependent kinase inhibitors
11/30/2010CA2482858C Tricyclic thrombin receptor antagonists
11/30/2010CA2456817C Alkyne-aryl-naphthyridin-4 (1h)-one derivatives as type iv phosphodiesterase inhibitor
11/30/2010CA2440218C Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
11/30/2010CA2315693C Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
11/30/2010CA2299295C Substituted tetrahydropyrane derivatives and method for producing same
11/25/2010WO2010135662A2 Marker differentially expressed in cancer stem cells and methods of using same
11/25/2010WO2010135650A1 N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
11/25/2010WO2010135621A1 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
11/25/2010WO2010135580A2 Fermented wheat germ proteins (fwgp) for the treatment of cancer
11/25/2010WO2010135579A1 Fluorinated diaryl urea derivatives
11/25/2010WO2010135568A1 Benzoxazepines as inhibitors of mtor and their use to treat cancer
11/25/2010WO2010135547A1 Antibodies directed to gpnmb and uses thereof
11/25/2010WO2010135524A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
11/25/2010WO2010135429A2 Compositions for modulating a kinase cascade and methods of use thereof
11/25/2010WO2010135242A1 Combinations of immunostimulatory agents, oncolytic virus, and additional anticancer therapy
11/25/2010WO2010135170A2 Nitrile derivatives and their pharmaceutical use and compositions
11/25/2010WO2010134614A1 SELF-EMULSIFYING COMPOSITION OF ω3 FATTY ACID
11/25/2010WO2010134601A1 Peptide inducing xage-1b-specific immune reaction and utilization of same
11/25/2010WO2010134588A1 Method for prediction of therapeutic effect of chemotherapy employing expression level of dihydropyrimidine dehydrogenase gene as measure
11/25/2010WO2010134039A2 Mitochondrial activity inhibitors of cancer-initiating cells and use thereof
11/25/2010WO2010133941A2 New hybrid particles and their use in diagnostics and therapy
11/25/2010WO2010133885A1 Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
11/25/2010WO2010133882A1 Disaccharin, difumaric acid, di-l-hydroxy-2-naphthoic acid and mono-benzoic acid salts of 4- (dimethylamin0)butyl 2- (4- ( (2-amino-4-methyl-6- (pentylamino) pyrimidin- 5 -yl) methyl) phenyl)acetate
11/25/2010WO2010133836A1 Fused bicyclic pyrazole derivatives as kinase inhibitors
11/25/2010WO2010133794A1 Anticancer compound and pharmaceutical composition containing the same
11/25/2010WO2010133748A1 Protease inhibitors
11/25/2010WO2010133687A1 Cycloartanone derivatives with anticancer activity
11/25/2010WO2010133672A1 Derivatives of quinoline-3-carboxylic acid and their medical use
11/25/2010WO2010133669A1 Substituted quinolines for use as vegf inhibitors
11/25/2010WO2010133647A1 Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
11/25/2010WO2010133534A1 Bicyclic amino substituted compounds as pi3k inhibitors
11/25/2010WO2010133009A1 A anti-tumor chinese drugs preparation comprising lucidum spores oil and preparation method thereof
11/25/2010WO2010114928A3 Propane- i-sulfonic acid {3- [5- (4 -chloro-phenyl) -1h-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof
11/25/2010WO2010112657A3 Pharmaceutical compositions for treating metastasis
11/25/2010WO2010107991A3 Use of ixolaris, a tissue factor inhibitor, for the treatment and prevention of cancer
11/25/2010WO2010105008A3 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
11/25/2010WO2010100515A3 Fractions of wheat germ ferment
11/25/2010WO2010099379A8 Jak kinase modulating quinazoline derivatives and methods of use thereof
11/25/2010WO2010095940A3 Glutathione-based drug delivery system
11/25/2010WO2010093615A3 Compounds, their syntheses, compositions, and methods to treat cancer
11/25/2010WO2010091679A3 Use of notch regulators for modulating the immune response by induction/suppression of interleukin-22
11/25/2010WO2010083311A3 Compositions and methods of use
11/25/2010WO2010083203A3 Non-embryonic stem cells and uses thereof
11/25/2010WO2010080817A3 Carbohydrate-cyclopamine conjugates as anticancer agents
11/25/2010WO2010080415A3 Substituted afpo (6-aryl-4h-furo[3,2-c]pyran-4-one) derivatives as anti-cancer agents
11/25/2010WO2010062143A9 Anticancer composition comprising antitumor agent and substance having inhibitory effects on l1cam activity and expression
11/25/2010WO2010049449A3 Novel salts of sunitinib
11/25/2010WO2010048623A3 Medical and imaging nanoclusters
11/25/2010WO2010033509A3 14-hydroxy-docosahexaenoic acid compounds
11/25/2010WO2009142893A3 Methods and compositions for the delivery of bioactive compounds
11/25/2010WO2009137871A8 Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells
1 ... 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 ... 2211